Accelerating Remote Patient Monitoring During the COVID-19 Pandemic Demands on healthcare resources continue to escalate as our aging population is living longer, often with more long-term health conditions. Changes to current practices are essential to help services keep up with the pressures placed upon them. Back in 2016, Simon Stevens (NHS England’s CEO) urged doctors,…
A report from Dr. Jörg Oliver Thumfart*, Labormedizinisches Zentrum Dr. Risch “We successfully introduced the automated, turbidimetric assay for fecal calprotectin, the BÜHLMANN fCAL® turbo, on our Roche cobas® c501 in Autumn 2019. The BÜHLMANN fCAL® turbo replaced a classical ELISA assay. The main motivation for this change was to increase flexibility in planning lab…
In this humbling account, Rose Stanley, wife of long term Crohn’s sufferer Lee, shares her experiences of how, together, they tackle the daily challenges of living with the disease. It reminds us of why efficient monitoring, to help individuals manage the condition themselves, is so important. “Life is not dissimilar to what everyone has experienced…
The recent merger of clinical services across Basildon, Southend and Broomfield, now forms the Mid and South Essex University Hospital Trust with a catchment population of 1.5 million. The Gastroenterology Department deals with the diagnosis and on-going management of patients with IBD. Patients who are diagnosed need regular monitoring in case of relapse/flare, to ensure…
In this pilot study, a relation between GI symptoms, intestinal inflammation (determined by FC) and faecal SARS-CoV-2-RNA in hospitalised patients with COVID-19 who did not require intensive care measures was explored. Click here to visit the BMJ website to find out more about the study and its results.
As you may have seen from the NEQAS reports, the BÜHLMANN fCAL® turbo calprotectin assay is proving very popular, and its use has grown significantly over the last few years. Some of these laboratories were already existing BÜHLMANN calprotectin assay users that have switched technologies from the Quantum Blue® rapid test or the fCAL ELISA.…